QMS Medical Allied Services Limited (NSE:QMSMEDI)
India · Delayed Price · Currency is INR 202.33
+9.62 (4.99%)
Oct 7, 2026, 3:27 PM IST
NSE:QMSMEDI Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,887 | 1,285 | 1,335 | 2,089 | 2,333 | - | |
Market Cap Growth | 111.40% | -3.74% | -36.10% | -10.44% | - | - |
Enterprise Value | 4,663 | 2,082 | 1,994 | 2,321 | 2,674 | - |
Last Close Price | 200.99 | 71.81 | 73.42 | 114.44 | 127.31 | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 36.82 | 12.68 | 11.04 | 23.21 | 36.58 | - |
PS Ratio | 2.12 | 0.74 | 0.86 | 1.71 | 2.24 | - |
PB Ratio | 3.41 | 1.13 | 1.25 | 2.66 | 3.31 | - |
P/TBV Ratio | 5.58 | 1.85 | 2.34 | 2.74 | 3.38 | - |
P/FCF Ratio | 28.47 | 9.41 | 8.49 | - | - | - |
P/OCF Ratio | 20.00 | 6.61 | 6.97 | 153.43 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.54 | 1.20 | 1.28 | 1.90 | 2.57 | - |
EV/EBITDA Ratio | 17.09 | 8.26 | 8.03 | 12.78 | 23.54 | - |
EV/EBIT Ratio | 20.12 | 9.48 | 9.24 | 15.53 | 25.96 | - |
EV/FCF Ratio | 34.16 | 15.25 | 12.67 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.65 | 0.65 | 0.56 | 0.44 | 0.36 | 1.03 |
Debt / EBITDA Ratio | 2.73 | 2.96 | 2.43 | 1.90 | 2.25 | 1.93 |
Debt / FCF Ratio | - | 5.46 | 3.83 | - | - | - |
Net Debt / Equity Ratio | 0.60 | 0.60 | 0.52 | 0.41 | 0.33 | 0.96 |
Net Debt / EBITDA Ratio | 2.49 | 2.69 | 2.26 | 1.77 | 2.04 | 1.80 |
Net Debt / FCF Ratio | - | 4.97 | 3.56 | -26.90 | -0.80 | -7.84 |
Asset Turnover | - | 0.86 | 0.96 | 0.97 | 1.04 | 2.05 |
Inventory Turnover | - | 2.17 | 2.12 | 2.37 | 2.88 | 4.95 |
Quick Ratio | - | 0.82 | 0.87 | 0.86 | 0.94 | 0.90 |
Current Ratio | - | 1.56 | 1.64 | 1.96 | 1.92 | 1.51 |
Return on Equity (ROE) | - | 10.78% | 14.76% | 12.09% | 12.58% | 41.61% |
Return on Assets (ROA) | - | 6.82% | 8.29% | 7.38% | 6.43% | 13.54% |
Return on Invested Capital (ROIC) | 9.26% | 9.23% | 11.57% | 10.77% | 9.78% | 23.02% |
Return on Capital Employed (ROCE) | - | 18.10% | 18.50% | 18.40% | 14.20% | 46.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.79% | 7.88% | 9.06% | 4.31% | 2.73% | - |
FCF Yield | 3.51% | 10.62% | 11.78% | -0.57% | -12.37% | - |
Dividend Yield | 0.25% | 0.70% | 0.68% | 0.44% | 0.39% | - |
Payout Ratio | - | 8.81% | 7.38% | 9.91% | - | - |
Buyback Yield / Dilution | -11.45% | -3.34% | -1.80% | -9.05% | -8.76% | -33.33% |
Total Shareholder Return | -11.20% | -2.64% | -1.12% | -8.61% | -8.37% | -33.33% |